scopolamine intranasal (Pending FDA Approval)

Brand and Other Names:
Sections

Dosing & Uses

Motion Sickness

Pending FDA approval to prevent motion sickness

Next:

Pharmacology

Mechanism of Action

Anticholinergic belladonna alkaloid

Generally exhibits pharmacologic actions associated with other antimuscarinic agents

May prevent motion-induced nausea and vomiting by blocking transmission of cholinergic impulse from vestibular nuclei to higher centers in CNS and from reticular formation to vomiting center

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.